Table 5.

Correlations of MR and CD163 expression in colorectal cancer tissues with major clinical variables

Clinical variables	MR in CRC tissues		CD163 in CRC tissues
	Median (P25-P75)	$P$ value	Median (P25-P75)	$P$ value
Age		0.4871		0.6972
$⩽$ 65 years	0.036(0.027–0.052)		0.098(0.061–0.134)
$>$ 60 years	0.040(0.032–0.050)		0.098(0.065–0.140)
Gender		0.8979		0.7634
Male	0.038(0.031–0.051)		0.095(0.064–0.132)
Famale	0.041(0.026–0.052)		0.100(0.066–0.137)
Differentiation		0.4809		0.3926
High $+$ Moderate	0.038(0.029–0.050)		0.094(0.065–0.130)
Low	0.042(0.033–0.055)		0.113(0.066–0.154)
Tumor size		0.8278		0.8228
$⩽$ 5 cm	0.038(0.028–0.053)		0.101(0.062–0.137)
$>$ 5 cm	0.040(0.031–0.048)		0.096(0.069–0.140)
T stage		0.0232		0.4983
T1–T2	0.033(0.021–0.045)		0.087(0.074–0.127)
T3–T4	0.040(0.031–0.055)		0.101(0.063–0.138)
N stage		0.0001		0.0001
N0	0.032(0.022–0.038)		0.069(0.046–0.091)
N1–N2	0.048(0.039–0.062)		0.130(0.102–0.157)
M stage		0.2877		0.0570
M0	0.038(0.029–0.050)		0.095(0.064–0.132)
M1	0.057(0.035–0.063)		0.161(0.101–0.188)
Clinical stage		0.0001		0.0001
I $+$ II	0.032(0.022–0.038)		0.069(0.046–0.091)
III $+$ IV	0.048(0.039–0.062)		0.130(0.102–0.157)